• Health & Medicine

Targeted lung cancer treatment gets initial ‘no’ for NHS in England

Adults in England with advanced lung cancer will not have access to a new targeted cancer drug, lorlatinib (Lorviqua).  Adults in England with advanced lung cancer will not have access to a new targeted cancer drug, lorlatinib (Lorviqua). 

4 February 2020

• Health & Medicine

Never too late to quit: protective cells could cut risk of lung cancer for ex-smokers

Protective cells in the lungs of ex-smokers could explain why quitting smoking reduces the risk of developing lung cancer. Protective cells in the lungs of ex-smokers could explain why quitting smoking reduces the risk of developing lung cancer.

29 January 2020

• Health & Medicine

Lung cancer immunotherapy gets initial ‘no’ for NHS in England

An immunotherapy and chemotherapy combo has been rejected for some adults with small cell lung cancer on the NHS in England. An immunotherapy and chemotherapy combo has been rejected for some adults with small cell lung cancer on the NHS in England.

8 January 2020

• Science & Technology

First-in-human trial for new lung cancer immunotherapy

Cancer Research UK and VOLT, announce a new partnership to bring a novel immunotherapeutic vaccine strategy to patients with lung cancer Cancer Research UK and VOLT, announce a new partnership to bring a novel immunotherapeutic vaccine strategy to patients with lung cancer

17 December 2019

• Science & Technology

Predicting lung cancer’s return at surgery

New lung cancer research shows that detecting potential tumour cells leaving the vein in the lung at surgery may predict the diseases return. New lung cancer research shows that detecting potential tumour cells leaving the vein in the lung at surgery may predict the diseases return.

7 October 2019

• Health & Medicine

Secrets of lung cancer spread found in patients' blood and biopsies

Three studies from Cancer Research UK's TRACERx project reveal early signs that lung cancer may spread and become untreatable. Three studies from Cancer Research UK's TRACERx project reveal early signs that lung cancer may spread and become untreatable.

7 October 2019

• Health & Medicine

Two lung cancer drugs approved and one rejected for NHS Scotland

Two lung cancer drugs have been made available through NHS Scotland while another drug has been rejected. Two lung cancer drugs have been made available through NHS Scotland while another drug has been rejected.

16 September 2019

• Health & Medicine

Lung cancer immunotherapy combo added to Cancer Drugs Fund

Combining an immunotherapy with chemotherapy has been recommended as a treatment for some patients with lung cancer on the NHS in England. Combining an immunotherapy with chemotherapy has been recommended as a treatment for some patients with lung cancer on the NHS in England.

8 August 2019

• Health & Medicine

One lung cancer drug receives NHS England approval, while another is rejected

A targeted drug has been accepted for routine use on the NHS in England for some adults with untreated, advanced lung cancer. A targeted drug has been accepted for routine use on the NHS in England for some adults with untreated, advanced lung cancer.

5 July 2019

• Health & Medicine

Kidney and lung cancer drugs approved on the NHS in Scotland

One kidney cancer treatment and two lung cancer drugs have been recommended for use on the NHS in Scotland. One kidney cancer treatment and two lung cancer drugs have been recommended for use on the NHS in Scotland.

12 June 2019

• Health & Medicine

NICE lung cancer U-turn boosts NHS treatment options in England

A combination treatment for some patients with advanced lung cancer will soon be made available on the NHS in England. A combination treatment for some patients with advanced lung cancer will soon be made available on the NHS in England.

7 May 2019

• Health & Medicine

Two targeted lung cancer drugs get initial ‘no’ for NHS in England

Patients with a certain type of lung cancer will not have access to two targeted cancer drugs on the NHS in England. Patients with a certain type of lung cancer will not have access to two targeted cancer drugs on the NHS in England.

12 April 2019